Intratumoural viral delivery improves glioblastoma survival
European Pharmaceutical Review
MAY 17, 2023
The viral therapy “aims to awaken the patient’s immune system and trigger a healing from within,” Dr Fueyo commented. After injection, patients that respond well develop inflammation inside the tumour, triggering an immune response that first kills the virus.” This makes it difficult to treat the cancer with immunotherapy.
Let's personalize your content